Lilly projects 2026 revenue of $82B-$85B and non-GAAP EPS of $35.50-$37 as Foundayo launch begins

Seeking Alpha — Apr 30, 19:12 PM

Read full article at Seeking Alpha →

GLP-1 drugs treat alcohol addiction

• Active ingredient in Ozempic shows early promise for treating alcohol use disorder ABC News — Apr 30, 22:45 PM
• US prescription spending could top $1 trillion. GLP-1s lead the way USA Today — Apr 30, 21:47 PM
• People with alcohol problems could benefit from taking weight loss jabs, researchers find The Independent — Apr 30, 22:30 PM
• Weight loss jabs could benefit those with alcohol problems, experts reveal LBC — Apr 30, 23:40 PM
• Health Care Roundup: Market Talk Wall Street Journal — Apr 30, 16:29 PM